BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 5627347)

  • 41. Hormone levels in threatened abortion.
    Brown JB; Evans JH; Beischer NA; Campbell DG; Fortune DW
    J Obstet Gynaecol Br Commonw; 1970 Aug; 77(8):690-700. PubMed ID: 5452130
    [No Abstract]   [Full Text] [Related]  

  • 42. Urinary steroid profile in threatened abortion.
    Acevedo HF; Vela BA; Campbell EA; Strickler HS; Gilmore J; Moraca JI; Arras BJ
    Am J Obstet Gynecol; 1969 Aug; 104(7):964-72. PubMed ID: 5794840
    [No Abstract]   [Full Text] [Related]  

  • 43. [Contributions to the androgen relationships during early pregnancy].
    Nyiri I; Takács I
    Z Arztl Fortbild (Jena); 1965 Mar; 59(6):305-10. PubMed ID: 5887889
    [No Abstract]   [Full Text] [Related]  

  • 44. [Excretion of steroid hormones in women with luteal insufficiency].
    Vrtílek V; Drác P
    Cesk Gynekol; 1966 Aug; 31(6):504-7. PubMed ID: 5925819
    [No Abstract]   [Full Text] [Related]  

  • 45. Pregnandiol excretion and corpus luteum therapy in habitual abortion.
    ALDER R
    Fertil Steril; 1953; 4(2):170-2. PubMed ID: 13033957
    [No Abstract]   [Full Text] [Related]  

  • 46. [Endocrine functions of the placenta].
    Jayle MF
    Rev Prat; 1972 Mar; 22(7):1015-27. PubMed ID: 5064413
    [No Abstract]   [Full Text] [Related]  

  • 47. Urinary steroid profile as an index of fetal well-being.
    Acevedo HF; Strickler HS; Gilmore J; Vela BA; Campbell EA; Arras BJ
    Am J Obstet Gynecol; 1968 Nov; 102(6):867-79. PubMed ID: 5686905
    [No Abstract]   [Full Text] [Related]  

  • 48. [Early placental insufficiency as a cause of abortion].
    Ragucci N; Morandi C; Passalia S
    Minerva Ginecol; 1967 Aug; 19(16):819-20. PubMed ID: 5605088
    [No Abstract]   [Full Text] [Related]  

  • 49. The postabortive ovarian disfunction (clinical, pathological and endocrine study).
    Botella-Llusiá J
    Gynecol Prat; 1972; 23(3):117-23. PubMed ID: 4661051
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hormonal and histologic studies in uterine myomas].
    Tóth F; Primász P; Dömötöri J
    Z Geburtshilfe Gynakol; 1969 Apr; 170(2):163-71. PubMed ID: 5784881
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prognostic value of gonadotropinuria in threatened abortion].
    Rondinelli M; Bonzani A; Brandi L
    Riv Ital Ginecol; 1967 Nov; 51(11):709-18. PubMed ID: 5616894
    [No Abstract]   [Full Text] [Related]  

  • 52. Simultaneous determination of urinary estrogens, individual 11-deoxy-17-ketosteroids, total 17-ketosteroids, total 17-ketogenic steroids, pregnanediol and plasma cortisol during the menstrual cycle and in early pregnancy.
    Adlercreutz H; Luukkainen T; Svangorg A
    Ann Med Exp Biol Fenn; 1967; 45(3):277-84. PubMed ID: 5583964
    [No Abstract]   [Full Text] [Related]  

  • 53. Corpus luteum deficiency as a cause of early recurrent abortion: a case history.
    Miller H; Durant JA; Ross DM; O'Connell FJ
    Fertil Steril; 1969; 20(3):433-8. PubMed ID: 5769391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary estrone glucuronide, pregnanediol glucuronide and human chorionic gonadotrophin in threatened abortion.
    Ishwad PC; Chitlange SM; Joshi UM; Chowdhury V; Mehta AC
    Int J Gynaecol Obstet; 1988 Aug; 27(1):107-11. PubMed ID: 2905284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of pregnanediol titre pattern on the fate of threatened abortion.
    Ghosh RN
    J Indian Med Assoc; 1976 Jan; 66(1):4-6. PubMed ID: 1270821
    [No Abstract]   [Full Text] [Related]  

  • 56. [THERAPEUTIC METHODS IN HABITUAL ABORTION. 1. ON PSYCHIATRIC, PHYSICAL, HORMONAL AND DRUG THERAPY].
    HANDA H
    Sanfujinka Chiryo; 1964 Mar; 8():300-4. PubMed ID: 14126429
    [No Abstract]   [Full Text] [Related]  

  • 57. Spontaneous abortion.
    McBride WZ
    Am Fam Physician; 1991 Jan; 43(1):175-82. PubMed ID: 1986486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prognosis and treatment of threatened abortion. C. Longitudinal study of normal and pathologic pregnancy using plasma hormone determinations].
    Crépin G; Delcroix M; Querleu D; Scholler R; Castanier M
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):73-8. PubMed ID: 7451885
    [No Abstract]   [Full Text] [Related]  

  • 59. [Measures to prevent threatened abortion].
    ISHIHAMA J; TOTTORI M
    Sanfujinka Chiryo; 1963 Jun; 6():622-7. PubMed ID: 13956833
    [No Abstract]   [Full Text] [Related]  

  • 60. [Determination of phenolsteroids and pregnanediol in normal pregnancy and in habitual abortion].
    JADRESIC A; AGUILO J; SAAVEDRA R; RAMIREZ H; HERREROS M; MATUS A
    Rev Chil Obstet Ginecol; 1961; 26():363-84. PubMed ID: 14450836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.